These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16700843)

  • 1. The neurobiological basis for partial agonist treatment of nicotine dependence.
    Aveyard P
    Int J Clin Pract; 2006 May; 60(5):507-8. PubMed ID: 16700843
    [No Abstract]   [Full Text] [Related]  

  • 2. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J
    Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatment of tobacco dependence].
    Friederich HM; Batra A
    Dtsch Med Wochenschr; 2009 Nov; 134(47):2402-5. PubMed ID: 19911331
    [No Abstract]   [Full Text] [Related]  

  • 4. A second varenicline trial.
    O'Brien CP
    Curr Psychiatry Rep; 2007 Oct; 9(5):346-7. PubMed ID: 17915071
    [No Abstract]   [Full Text] [Related]  

  • 5. A new medication for the worst addiction.
    O'Brien CP
    Curr Psychiatry Rep; 2007 Oct; 9(5):345-6. PubMed ID: 17915070
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotine gum dependence treated with varenicline--a case report.
    Garelik DA
    Nicotine Tob Res; 2010 Oct; 12(10):1041-2. PubMed ID: 20829327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for tobacco dependence.
    Treat Guidel Med Lett; 2008 Sep; 6(73):61-6. PubMed ID: 18719526
    [No Abstract]   [Full Text] [Related]  

  • 8. Varenicline for smokeless tobacco dependence.
    Aggarwal A; Jain M; Jiloha RC
    J Postgrad Med; 2010; 56(1):50. PubMed ID: 20393259
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
    Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE
    Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline reduced smoking behaviour in a mentally ill person.
    Ochoa EL
    J Psychopharmacol; 2009 May; 23(3):340-1. PubMed ID: 18562426
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced affective symptoms during tobacco dependence treatment with varenicline.
    Grosshans M; Mutschler J; Hermann D; Mann K; Diehl A
    Addiction; 2009 May; 104(5):859-61. PubMed ID: 19413797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors].
    Králíková E
    Cas Lek Cesk; 2006; 145(11):832-4. PubMed ID: 17168413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
    Crane R
    Prim Care; 2007 Mar; 34(1):117-35. PubMed ID: 17481990
    [No Abstract]   [Full Text] [Related]  

  • 16. Varenicline (Chantix) for tobacco dependence.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotine receptor partial agonists for smoking cessation.
    Lin KW
    Am Fam Physician; 2011 Oct; 84(7):769. PubMed ID: 22010613
    [No Abstract]   [Full Text] [Related]  

  • 18. Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines.
    Reus VI; Smith BJ
    Int J Clin Pract; 2008 Nov; 62(11):1753-68. PubMed ID: 18795968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.